Purpose and Medical Goals The primary goal of developing Semaglutide was to improve blood sugar control and aid in weight loss for individuals with type 2 diabetes
Common name: GHK-Cu, copper tripeptide, copper peptide GHK-Cu Chemical name: glycyl-L-histidyl-L-lysine: complex with copper(II) Synonyms: Copper peptide GHK-Cu, copper tripeptide-1, GHK-Cu, copper prezatide Peptide sequence: Gly-His-Lys (GHK) CAS number: 49557-75-7 (GHK-Cu)
Contact your provider promptly for persistent injection site reactions showing signs of infection, new or changing skin lesions, unexplained rash lasting more than a few days, or severe hair loss
No protocol is universally "best." The right choice depends on your history with GLP-1 agonists, your GI sensitivity, your access to appropriate syringes, your willingness to manage reconstitution at lower concentrations, and your goals
Y., Ha, J
References de Bray A, Roberts AG, Armour S, Tong J, Huhn C, Gatin-Fraudet B, Romann K, Shilleh AH, Jiang W, Figueredo Burgos NS, Trott JPP, Viloria K, Nasteska D, Pearce A, Miyazaki S, Tomlinson JW, Owen DM, Nieves DJ, Ast J, Cyranka M, Epanchintsev A, mml C, Reimann F, Soykan T, Ladds G, Adriaenssens AE, Trapp S, Jones B, Broichhagen J, Hodson DJ